How Active Patients Affect Dental Practice Value

What can active patients change in a valuation?

A verified patient count can test the demand assumed in a practice's earnings. It can expose dependence on a small group, explain a change in receipts, or challenge a growth plan. It cannot set a price on its own. The useful question is which part of the proposed operation would change if the patient evidence were different.

Start with the full valuation framework, including the earnings measure and assets being valued. Then locate the patient assumption inside that work. If the existing earnings already include receipts from the same people, those receipts are not a new benefit to add again. If the count reveals a gap in the forecast, show the specific change in work, receipts and costs.

This guide begins after the underlying population has been checked. The active-patient audit covers report filters, duplicate records and return cohorts. Here, the deliverable is a short explanation of whether that evidence supports, changes or leaves open an assumption used in the price discussion.

Which patient measure belongs beside the price?

Keep the definition beside every count. The ADA's policy includes patients served within the prior 24 months, with separate wording for the most recent 12 months. That policy is not a price formula. ADA: Active versus inactive patients.

The count used in a commercial review may need several views of recency. A longer period can include people whose recent receipts differ from those of more frequent visitors. Choose a view that tests the forecast, and show the other useful views without switching labels midstream. Do not label every person outside a chosen short window as a lost patient.

Open Dental's Active Patients Report uses completed procedures within a selected date range and offers status, provider and clinic filters. Open Dental: Active Patients Report. Save the actual definition used by the practice. The software feature describes an extraction method; it does not settle which population best fits the valuation.

Why can equal counts support different earnings?

Two practices can serve the same number of people and collect different amounts. Differences may reflect fees, completed services, payment timing or the period measured. Even equal collections can leave different earnings after staffing and other costs. Before treating the count as a value driver, identify which of those links is supported.

The ADA's purchase guidance asks about patient activity, new-patient flow and recall, alongside financial reports by doctor and hygienist. ADA: Practice purchase review. Use those separate views to test the story rather than compress them into a single score.

A receipts average is descriptive. Dividing money by people does not establish the next year's treatment needs or a price per patient. One large completed treatment can lift an average without changing the wider patient base. A fee increase can lift collections with no count growth. More people can also arrive while the time or cost needed to serve them rises.

Ask whether the proposed buyer can provide the services included in the historical result. Keep any clinical assessment with qualified clinicians. If a buyer would change the service scope, the value discussion needs that operating assumption even if every patient remains with the office.

What does an original patient-to-earnings case show?

The following case is invented for arithmetic. It is not a market benchmark, a patient forecast, a clinical recommendation or an actual practice. Assume the reviewed population contains 1,800 distinct people. Receipts for the chosen historical year are traceable to the two nonoverlapping groups below. The groups describe receipts only; they do not rank patients or predict care.

The starting practice has $1,080,000 of receipts and $300,000 of defined annual operating earnings. Those earnings already reflect the labor needed to deliver the work, including the owner's replacement clinical duties, and the other supplied operating costs. They are before acquisition debt, income tax and new capital spending. This simplified exercise does not establish a formal EBITDA figure or asset value.

Group B supplies $480,000 of receipts from 300 people. That fact makes the mix worth understanding. It does not prove that these people will leave, that their care will repeat, or that the practice has a clinical problem. The analyst needs evidence about the completed work and the forecast before making any of those claims.

For the price illustration only, assume someone applies a fixed factor of 3 to the defined earnings. The starting arithmetic is $300,000 × 3 = $900,000. The factor is supplied solely to make the earnings effect visible. It is not a recommended multiple, an observed sale, or an estimate of what a buyer will pay.

How much does the affected group matter?

Test a hypothetical reduction of 150 people from Group A. Assume their annual receipts would otherwise match that group's supplied average of $400. Receipts fall by $60,000. Assume only $12,000 of related costs can be avoided, equal to 20% of those lost receipts. All other costs stay in place. The earnings loss is therefore $48,000, leaving $252,000.

Now restore the original case and change a different assumption: remove 150 people from Group B instead. At the supplied $1,600 average, receipts fall by $240,000. Assume avoidable costs are $96,000, or 40% of those receipts, because this invented work has a different cost pattern. The earnings loss is $144,000, leaving $156,000.

The first two downside cases remove the same number of people. Their earnings effects differ because the supplied receipts and avoidable costs differ. Applying one average price reduction per person would miss that distinction. The case shows why the economic link matters; it does not predict which patients a real buyer would retain.

The last row changes only the annual coverage cost from the Group A case. The added $10,000 lowers earnings from $252,000 to $242,000 and the assumed price result by $30,000. The reduced patient count stays the same. A staffing response can thus change the model even when the patient assumption does not change.

When should the count leave the model unchanged?

A corrected label does not always change the economics. Suppose a new report includes a broader group, but all related receipts and costs were already included in the starting earnings. The report may improve the description of demand. It does not create incremental earnings merely because the total patient count is larger.

Likewise, a narrower count may exclude people whose past receipts were outside the earnings period already used. The analyst should check the connection before reducing both the count and the price. The correct response may be a clearer note, a revised forecast or no numerical change. It depends on what the earlier model actually assumed.

Preserve that reasoning in the valuation file. State the original claim, the corrected fact and the affected input. If no input changes, explain why. This lets a seller defend valid earnings without insisting that every headline metric must look stronger. It also gives a buyer a precise way to raise a concern without applying an arbitrary discount.

Can a patient premium count the same value twice?

Yes, if it pays twice for the same benefit under the method being used. A practice value based on earnings may already include the patient relationships that support those earnings. Adding a separate amount for each existing patient needs a distinct reason and a method that supports it. The count alone is not that reason.

Ask the analyst what the separate amount represents. Does it reflect an asset excluded from the first conclusion, a different valuation approach used as a cross-check, or simply the same future receipts again? A cross-check should help assess a conclusion. It should not automatically be added to that conclusion.

The same concern applies to growth. If projected earnings already assume a successful reactivation plan, do not also apply an unexplained patient-growth premium for the same success. Keep the operating assumption and the choice of valuation factor visible. If both change, explain the separate evidence for each change.

Use the SDE and earnings guide for the underlying earnings definition. This patient analysis should feed a documented model, not create a second informal valuation beside it.

How should a seller present strength without overpromising?

Show evidence that helps a buyer assess the actual operation. Present the count definition, relevant time periods, aggregate receipts mix and the cost assumptions needed to maintain the work. Explain unusual changes. Strong evidence may reduce an open question even when it does not justify a separate premium.

Avoid describing patients as guaranteed revenue that transfers with the files. The ADA's autonomy principle addresses patient self-determination, treatment involvement and confidentiality. ADA: Patient autonomy. The commercial model must leave treatment choices with patients and their clinical team.

Keep initial outreach seller-blind. Obtain an NDA before identifying disclosure to qualified buyers. Plan staff participation around the data work, actual duties and transition needs. That commercial process must remain separate from patient privacy, clinical authority and required notices. Ask the privacy lead and healthcare counsel to define any necessary record-level review; ordinary sale spreadsheets should use appropriately prepared aggregate results.

What evidence would justify changing the assumption?

A useful update resolves a named uncertainty. If the concern is a narrow concentration of historical receipts, request a supported distribution and service-period explanation. If it is dependence on a departing clinician, review the proposed coverage and costs. If it is missing recent demand, identify which dated evidence would support the next period's forecast.

Set a decision date and use the same reporting basis for the update. A later rise in the total count does not answer every earlier question. It may come from different filters or a wider observation period. A new appointment also does not establish completed care and payment. Name exactly what changed before carrying a benefit into the model.

For a DSO offer, locate the patient assumptions in the buyer's earnings case and any contingent price terms. For an individual buyer, connect the revised case with the acquisition financing review. Neither buyer type has a universal price per active patient. Obtain feedback on the actual evidence and proposed operation.

Common mistakes in patient-based value discussions

Do not multiply a count by an unsupported dollar amount and call the result goodwill. Do not apply a decline to total practice receipts when the affected group generated a different amount. Do not reduce revenue while removing costs that would still be paid. Each shortcut conceals the economic assumption that the parties need to discuss.

Avoid labeling higher receipts per person as better care or more attractive patients. The measure describes money in a period. It can prompt a qualified review of concentration and service mix, but it cannot establish treatment need or quality. The goal is a sound business assumption, not a clinical target.

Finally, do not use a downside case as evidence that losses will occur. Keep observed facts, proposed changes and hypothetical tests clearly labeled. A sensitivity is useful because it can be changed. It becomes misleading when its inputs are repeated later as if they were findings.

Summary

Active patients affect practice value through the receipts, costs and risks that the evidence supports. A count change deserves a price response only after the analyst identifies what changes in the underlying model. Keep separate premiums and growth plans from duplicating earnings already valued. Bring the defined population, the earnings bridge and unresolved assumptions to a confidential discussion with Jason Taken.